• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经蝶窦手术治疗肢端肥大症

The treatment of acromegaly by transsphenoidal surgery.

作者信息

Tucker H S, Grubb S R, Wigand J P, Watlington C O, Blackard W G, Becker D P

出版信息

Arch Intern Med. 1980 Jun;140(6):795-802.

PMID:7387274
Abstract

Pituitary tumors were removed transsphenoidally in 32 patients with acromegaly. Ten patients had high prolactin (PL) levels as well as elevated growth hormone (GH) levels. In 24 patients, GH levels were lowered to 5 ng/mL or less and remained low. The PL level was reduced to normal in eight patients. Of three patients with postoperative GH levels of 6 to 10 ng/mL, one patient remains in this range but two have relapsed. Five patients showed only a partial lowering in GH level. Pituitary irradiation lowered the level further. Hypopituitarism developed in four patients. Permanent diabetes insipidus occurred in one patient and meningitis developed in another. They subsequently recovered. There were no deaths. Abnormal GH responses to hyperglycemia, hypoglycemia, and levodopa returned to normal following surgery. Transsphenoidal tumor removal appears to be an effective treatment for acromegaly.

摘要

32例肢端肥大症患者经蝶窦切除垂体肿瘤。10例患者催乳素(PL)水平高,生长激素(GH)水平也升高。24例患者的GH水平降至5 ng/mL或更低并维持在低水平。8例患者的PL水平降至正常。术后GH水平为6至10 ng/mL的3例患者中,1例仍处于该范围,但2例复发。5例患者的GH水平仅部分降低。垂体放疗使水平进一步降低。4例患者发生垂体功能减退。1例患者出现永久性尿崩症,另1例发生脑膜炎。他们随后康复。无死亡病例。术后对高血糖、低血糖和左旋多巴的异常GH反应恢复正常。经蝶窦肿瘤切除似乎是肢端肥大症的有效治疗方法。

相似文献

1
The treatment of acromegaly by transsphenoidal surgery.经蝶窦手术治疗肢端肥大症
Arch Intern Med. 1980 Jun;140(6):795-802.
2
A prospective analysis of 151 cases of patients with acromegaly operated by one neurosurgeon: a follow-up of more than 23 years.一位神经外科医生对151例肢端肥大症患者进行手术的前瞻性分析:超过23年的随访。
Surg Neurol. 2006 Jul;66(1):26-31; discussion 31. doi: 10.1016/j.surneu.2005.11.063.
3
Presurgical octreotide treatment in acromegaly: no improvement of final growth hormone (GH) concentration and pituitary function. A long-term case-control study.肢端肥大症的术前奥曲肽治疗:最终生长激素(GH)浓度和垂体功能无改善。一项长期病例对照研究。
Acta Neurochir (Wien). 2005 May;147(5):485-93; discussion 493. doi: 10.1007/s00701-005-0511-9. Epub 2005 Apr 4.
4
[Surgical results and clinical analysis of 19 cases of acromegaly].19例肢端肥大症的手术结果及临床分析
Hokkaido Igaku Zasshi. 1985 Mar;60(2):241-51.
5
A clinicomorphological study of pituitary tumors associated with the clinical syndrome of acromegaly.与肢端肥大症临床综合征相关的垂体肿瘤的临床形态学研究
Exp Clin Endocrinol. 1991;98(3):223-7. doi: 10.1055/s-0029-1211121.
6
Changes in serum glucose and serum growth hormone levels during pituitary surgery.垂体手术期间血清葡萄糖和血清生长激素水平的变化。
Anesth Analg. 1987 Aug;66(8):746-50.
7
Clinical indicators of biochemical remission in acromegaly: does incomplete disease control always mean therapeutic failure?肢端肥大症生化缓解的临床指标:疾病控制不完全是否总是意味着治疗失败?
Clin Endocrinol (Oxf). 2005 Apr;62(4):410-7. doi: 10.1111/j.1365-2265.2005.02233.x.
8
Acromegaly: biochemical assessment of cure after long term follow-up of transsphenoidal selective adenomectomy.肢端肥大症:经蝶窦选择性腺瘤切除术后长期随访的治愈生化评估
J Clin Endocrinol Metab. 1985 Dec;61(6):1185-9. doi: 10.1210/jcem-61-6-1185.
9
Prolactin concentrations in patients with acromegaly: clinical significance and response to surgery.肢端肥大症患者的催乳素浓度:临床意义及对手术的反应
Clin Endocrinol (Oxf). 1976 Jan;5(1):63-9.
10
Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.库欣病治疗后获得性催乳素缺乏(APD)是不可逆性严重生长激素缺乏(GHD)的可靠标志物,但不能反映疾病状态。
Clin Endocrinol (Oxf). 2004 Apr;60(4):476-83. doi: 10.1111/j.1365-2265.2004.02004.x.

引用本文的文献

1
Microsurgical versus endoscopic transsphenoidal resection for acromegaly: a systematic review of outcomes and complications.经蝶窦显微手术与内镜手术治疗肢端肥大症的系统评价:疗效与并发症分析
Acta Neurochir (Wien). 2017 Nov;159(11):2193-2207. doi: 10.1007/s00701-017-3318-6. Epub 2017 Sep 14.
2
Surgery induced hypopituitarism in acromegalic patients: a systematic review and meta-analysis of the results.肢端肥大症患者手术所致垂体功能减退:结果的系统评价与荟萃分析
Pituitary. 2015 Dec;18(6):844-60. doi: 10.1007/s11102-015-0661-6.
3
Effect of surgery and radiotherapy on visual and endocrine function in nonfunctioning pituitary adenomas.
手术和放疗对无功能垂体腺瘤视觉及内分泌功能的影响。
J Endocrinol Invest. 1998 May;21(5):284-90. doi: 10.1007/BF03350330.
4
Two-step development of a pituitary adenoma: from hyperprolactinemic syndrome to Cushing's disease.垂体腺瘤的两步发展:从高催乳素血症综合征到库欣病。
J Endocrinol Invest. 1997 Apr;20(4):240-4. doi: 10.1007/BF03346911.
5
Recovery of visual and endocrine function following transsphenoidal surgery of large nonfunctioning pituitary adenomas.大型无功能垂体腺瘤经蝶窦手术后视觉和内分泌功能的恢复
J Endocrinol Invest. 1994 Oct;17(9):703-7. doi: 10.1007/BF03347763.
6
Acromegaly with 'normal' growth hormone levels.生长激素水平“正常”的肢端肥大症
West J Med. 1985 Jan;142(1):95-7.
7
Criteria for the cure of acromegaly: comparison between basal growth hormone and somatomedin C plasma concentrations in active and non-active acromegalic patients.肢端肥大症的治愈标准:活跃期与非活跃期肢端肥大症患者基础生长激素和血浆生长调节素C浓度的比较
J Endocrinol Invest. 1988 Jan;11(1):57-60. doi: 10.1007/BF03350100.
8
Endocrinological differentiation of primary hypothalamic and pituitary disease.原发性下丘脑和垂体疾病的内分泌分化
Acta Neurochir (Wien). 1985;75(1-4):91-8. doi: 10.1007/BF01406328.